Texas Instruments financial results, Union Pacific operating metrics, and BeOne Medicines share sale
Texas Instruments reported higher key financial metrics, Union Pacific showed increased shipping volumes, and a BeOne Medicines director sold all his shares.
Texas Instruments revenue rose to $6.06 billion
Texas Instruments reported third-quarter revenue of $6.06 billion, a 28% increase from the same period last year. Operating profit rose 73%, and net income increased 78%. Management cited demand in the industrial, automotive, and data center sectors.
BeOne Medicines director sold all his shares
Wang Xiaodong, a director and chair of the scientific advisory board at BeOne Medicines, sold all his shares in the company on October 13, 2026. He disposed of 31,027 shares for a total of $10.89 million at an average price of $350.99 per share. Following the transaction, his stake is zero. The sale was made under a Rule 10b5-1 trading plan, a preset selling schedule executives set up in advance.
Union Pacific third-quarter operating metrics
Union Pacific increased shipping volumes by 6% in the third quarter. Freight car velocity rose 1%, and terminal dwell time decreased by 2%.
Original sources
- Texas Instruments Inc: 8-K EX-99 filing, October 21, 2026
- BeOne Medicines Ltd.: 4 filing, October 15, 2026
- Jim Vena: Moving America Forward
Cite this article
The fingerprint identifies the exact version of each original that the article was written from; the original stays at its source.
Alerts for your companies
The daily briefing as a notification in your browser or on your phone. Free, no email, no account, no app.
Prepared by AI from official company documents; automatic checks and an AI editor review it before publication, and not every article is read by a person. This is not investment advice. Editorial standards
